Antibody production
-
Antibody productionWhat are chimeric antibodies?
Philippe Funfrock
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such as humanized and human antibodies. Today, these structural chimeras represent…
-
Fully human antibodies that will make the news in 2020
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More
-
Why humanized antibody production may thrive in the 2020s
For the first time, humanized and fully human antibodies are almost on equal terms. Up to 2019, 38 humanized antibodies… Read More
-
Antibody production: rabbit versus mouse, which host best fits your project?
In recent years, rabbit monoclonal antibody production using phage display has been sought after by researchers and industry leaders… Read More
-
Antibody therapeutics in clinical trials for the treatment of COVID-19
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of… Read More
-
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More
-
How is antibody therapy changing the way we treat HIV?
The ever-elusive cure for human immunodeficiency virus (HIV) infection continues to be out of reach for most patients. But the… Read More
-
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Uniquely poised between research labs and the clinic, Professor Tomáš Kalina and his team at the Charles University in Prague,… Read More
-
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Intrigued by how parasites are able to elude our immune system, Professor Richard Pleass from the Liverpool School of Tropical… Read More
-
5 strategies to skyrocket the potency of monoclonal antibody therapy
Every year since 2014, at least 6 new monoclonal antibody therapies enter the clinic. These molecules are designed to target… Read More
